Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (31-40 of 331) with videos related to

Pageof 34
Sort By:
JAMA Oncology|April 15, 2016
Relationship of Industry Sponsorship to Results of Cost-Effectiveness Analyses of Drugs Used in Breast Cancer Treatment--ReplyCharles L Bennett, Jordan D Lane
Seminars in Thrombosis and Hemostasis|January 3, 2006
Thrombotic thrombocytopenic purpura-2005Hau C Kwaan, Charles L Bennett
Urology|January 1, 2013
Editorial commentSandip M Prasad, Charles L Bennett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2013
Finishing the picture: problems with public reporting of clinical trialsSandip M Prasad, Charles L Bennett
Urology|January 14, 2026
Editorial Comment on "Global Disparities in Urological Research: A Systematic Bibliometric Analysis of Low- and Middle-Income Country (LMIC) Representation in Urology Journals from 2013 - 2023?"Andrew C Bennett, Charles L Bennett
Drugs & Aging|May 17, 2003
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?Charles L Bennett, Glen T Schumock
Journal of Nephrology|September 21, 2013
Forewarned is forearmed: erythropoietin use in CKD patients with cancerSamuel J Kessler, Charles L Bennett
JCO Oncology Practice|December 18, 2020
Contemporary Clinical Trials Office: Doing More With LessKenneth R Carson, Charles L Bennett
JAMA Network Open|October 6, 2023
Risk of Recurrence After Radiation in Early Prostate Cancer-Role of Risk Stratification From Prospective TrialsMartin W Schoen, Charles L Bennett
American Journal of Hematology/Oncology|August 19, 2011
Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated AnemiaAthena T Samaras, Charles L Bennett
Pageof 34

Showing results (31-40 of 331) with videos related to

Sort By:
Pageof 34
JAMA Oncology|April 15, 2016
Relationship of Industry Sponsorship to Results of Cost-Effectiveness Analyses of Drugs Used in Breast Cancer Treatment--ReplyCharles L Bennett, Jordan D Lane
Seminars in Thrombosis and Hemostasis|January 3, 2006
Thrombotic thrombocytopenic purpura-2005Hau C Kwaan, Charles L Bennett
Urology|January 1, 2013
Editorial commentSandip M Prasad, Charles L Bennett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2013
Finishing the picture: problems with public reporting of clinical trialsSandip M Prasad, Charles L Bennett
Urology|January 14, 2026
Editorial Comment on "Global Disparities in Urological Research: A Systematic Bibliometric Analysis of Low- and Middle-Income Country (LMIC) Representation in Urology Journals from 2013 - 2023?"Andrew C Bennett, Charles L Bennett
Drugs & Aging|May 17, 2003
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?Charles L Bennett, Glen T Schumock
Journal of Nephrology|September 21, 2013
Forewarned is forearmed: erythropoietin use in CKD patients with cancerSamuel J Kessler, Charles L Bennett
JCO Oncology Practice|December 18, 2020
Contemporary Clinical Trials Office: Doing More With LessKenneth R Carson, Charles L Bennett
JAMA Network Open|October 6, 2023
Risk of Recurrence After Radiation in Early Prostate Cancer-Role of Risk Stratification From Prospective TrialsMartin W Schoen, Charles L Bennett
American Journal of Hematology/Oncology|August 19, 2011
Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated AnemiaAthena T Samaras, Charles L Bennett
Pageof 34